January 12, 2026 07:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Markets rally big after US envoy calls India White House’s ‘most important ally’ | Kite diplomacy in Ahmedabad: Modi, German Chancellor share rare moment | ‘No ally more important than India’: US envoy sparks stock market rally | ED moves Supreme Court seeking CBI FIR against Mamata Banerjee over I-PAC raid chaos | Youngest ever! Owen Cooper wins Golden Globe as Adolescence dominates awards night | Timothée Chalamet beats DiCaprio, Clooney to win Golden Globe for Marty Supreme | Golden Globes 2026: DiCaprio’s film, Netflix series steal the show | IPAC raid row escalates! ED drags Mamata Banerjee to Supreme Court after High Court chaos | 'Easy way or hard way': Trump doubles down on controversial push to acquire Greenland | Hindu tenant farmer shot dead in Pakistan’s Sindh, sparks massive protests
India-Canada
Image Credit: Covishield Twitter handle

India commits to ship Covishield vaccines to Canada within a month

| @indiablooms | Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" Poonawalla said in a tweet, using the brand name under which Serum produces the shot developed by Oxford University and AstraZeneca Plc.

Earlier, Canada's Prime Minister Justin Trudeau had also been assured by India's Prime Minister Narendra Modi during their discussion on Monday, that India would do its best to supply COVID-19 vaccines sought by Canada.

"Minister Anand continues to make every effort to ensure that vaccines are delivered to Canada as early as possible from a diverse range of suppliers. We will announce details of any agreement once it is finalized," said James Fitz-Morris in an email.

Approval of two separate applications for a vaccine developed by AstraZeneca and Oxford University researchers, including a joint pitch from SII, a private enterprise in Pune in western India, is being reviewed by Health Canada.

Canada has a deal with AstraZeneca for 20 million doses.

(Reporting by Asha Bajaj)
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.